Super User
Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands
Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcazar-Corcoles, M. A., & Bouso, J. C. (2022). Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands. Journal of Psychoactive Drugs, 1–12.
Do psychedelics have therapeutic potential for obesity?
Fadahunsi, N., Knudsen, G. M., & Clemmensen, C. (2023). Do psychedelics have therapeutic potential for obesity? Nature Reviews. Endocrinology, 19(1), 1–2.
Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies
Borgland, S. L., & Neyens, D. M. (2022). Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies. Journal of Psychiatry & Neuroscience: JPN, 47(3), E218–E221.
Psychedelics and Health Behavior Change
Our research group studies motivational and self-regulatory determinants of health-related behaviors, such as physical activity and healthy eating. This particular research line aims at testing whether the experience of alternative states of consciousness changes the adoption and regulation of these behaviors and, if so, by which mechanisms. Access our review paper detailing this hypothesis HERE. More details about our studies HERE and through the links below.
Related Selected Research
-
Borgland, S. L., & Neyens, D. M. (2022). Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies. Journal of Psychiatry & Neuroscience: JPN, 47(3), E218–E221.
-
Fadahunsi, N., Knudsen, G. M., & Clemmensen, C. (2023). Do psychedelics have therapeutic potential for obesity? Nature Reviews. Endocrinology, 19(1), 1–2.
-
Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcazar-Corcoles, M. A., & Bouso, J. C. (2022). Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands. Journal of Psychoactive Drugs, 1–12. Advance online publication.
-
Neuhaus, E. C., & Slavich, G. M. (2022). Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience. Frontiers in Psychiatry / Frontiers Research Foundation, 13:821208.
-
Ona, G., Kohek, M., Massaguer, T., Gomariz, A., Jiménez, D. F., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2019). Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users. Journal of Psychoactive Drugs, 51(2), 135–145.
-
Simonsson, O., Hendricks, P. S., Carhart-Harris, R., Kettner, H., & Osika, W. (2021). Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year. Hypertension, 77(5), 1510–1516.
-
Simonsson, O., Hendricks, P. S., Chambers, R., Osika, W., & Goldberg, S. B. (2022). Classic psychedelics, health behavior, and physical health. Therapeutic Advances in Psychopharmacology, 12, 20451253221135363.
-
Simonsson, O., Osika, W., Carhart-Harris, R., & Hendricks, P. S. (2021). Associations between lifetime classic psychedelic use and cardiometabolic diseases. Scientific Reports, 11(1), 14427.
-
Simonsson, O., Sexton, J. D., & Hendricks, P. S. (2021). Associations between lifetime classic psychedelic use and markers of physical health. Journal of Psychopharmacology, 35(4), 447–452.
-
Teixeira, P. J., Johnson, M. W., Timmermann, C., Watts, R., Erritzoe, D., Douglass, H., Kettner, H., & Carhart-Harris, R. L. (2022). Psychedelics and health behaviour change. Journal of Psychopharmacology, 36(1), 12–19.
Luisa Prochazkova
Luisa Prochazkova finished her Ph.D. at the Cognitive Psychology Unit, Leiden University under the supervision of Prof. Dr. Bernhard Hommel and Dr. Roberta Sellaro. In her PhD project, funded by a European Research Council (ERC) Consolidator grant, she worked on the questions of how cognitive control affects the interplay between so-called intentional and automatic processes. In particular, she investigates how the ability to maintain behavioural goals is dictated by current metacontrol state bias and how is such bias induced. To this end, Luisa studies the effect of drugs (psychedelics/microdosing), meditation, changes in the autonomic nervous system and reward processing on the metacontrol policies. Furthermore, Luisa is interested in improving existing VR-mindfulness games by implementing biofeedback to monitor and aid emotional responses and psychophysiological states during training.
Talea Cornelius
Talea Cornelius is a health psychologist and Assistant Professor of Medical Sciences at Columbia University Irving Medical Center. Her research situates mental health and health behaviors within a social context. In particular, she explores how an acute medical event, such as an acute coronary syndrome or a stroke, impacts patients and partners alike, and how partners can both facilitate and undermine patient well-being. Dr. Cornelius is also exploring novel applications of dyadic analysis to gain insight into interdependent, individual-level processes.
Psychedelics and Health Behavior Change
Psychedelic Experiences, Physical Health and Health Behavior Change. More info HERE.
Context, Social Dynamics & Lived Experience
Context, Social Dynamics & Lived Experience
Understanding how and why change happens
- Ceremonial, digital, and group contexts
- Relational and shared experiences
- Practitioner perspectives and facilitation
- Subjective experiences (e.g., mystical-type experiences)
Michiel van Elk
Michiel van Elk completed his PhD in Cognitive Neuroscience at the Donders Institute in Nijmegen (cum laude). He worked as a visiting researcher at the University of California Santa Barbara (2010), as a Marie Curie post-dotoral fellow at the École Polytechnique Fédérale de Lausanne in Switzerland (2010-2012), as a Fulbright Scholar at Stanford University (2017), as a Research Fellow at the Netherlands Institute for Advanced Studies (NIAS) in Amsterdam (2019-2010) and as Assistant Professor at the University of Amsterdam (2013-2020). Since 2020 Michiel is affiliated as Associate Professor to the University of Leiden and as an affiliate researcher at VU University. Supported by grants from the Templeton Foundation, NWO and the BIAL Foundation he supervises the PRSM Lab, which focuses on the study of Psychedelic, Religious, Spiritual and Mystical Experiences. By using a variety of different techniques, including self-report measures, interviews, expectancy manipulations, neuroimaging tools, psychophysiological techniques and pharmacological challenges the aim of the lab is to understand how PRSM experiences come about, the effects they have on our behavior and well-being and the philosophical implications of PRSM experiences for our views on the self and reality.